Korean J Nephrol.  2010 Mar;29(2):260-264.

The Use of Single-pass Albumin Dialysis to Correct Severe Hyperbilirubinemia in Acute Hepatitis A: A Case Report

Affiliations
  • 1Division of Nephrology and Hypertension, Inha University College of Medicine, Incheon, Republic of Korea. nhkimj@inha.ac.kr
  • 2Division of Gastroenterology, Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.

Abstract

In cases of acute liver failure or acute or chronic liver failure, extracorporeal albumin dialysis utilizing a Molecular Adsorbent Recirculating System has been used to treat liver failure and to reduce serum total bilirubin concentrations as a bridge therapy until either liver transplantation or spontaneous recovery. However, the procedure is expensive and is not easily administered in clinical practice. Recently, single pass albumin dialysis (SPAD) using continuous renal replacement therapy was introduced, but information is scarce regarding its efficacy in controlling serum bilirubin. The authors report a case of acute hepatitis A, in which SPAD was performed to correct severe hyperbilirubinemia.

Keyword

Hyperbilirubinemia; Extracorporeal dialysis; Albumin

MeSH Terms

Bilirubin
Dialysis
End Stage Liver Disease
Formaldehyde
Hepatitis
Hepatitis A
Hyperbilirubinemia
Liver Failure
Liver Failure, Acute
Liver Transplantation
Polymers
Renal Dialysis
Renal Replacement Therapy
Resorcinols
Bilirubin
Formaldehyde
Polymers
Resorcinols
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr